Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9806	Companies
196689	Keywords
127705	Articles
104572	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 08/28/2025 at 07:00, 5 months 8 days ago

Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie
Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie. La société se prépare à recruter des patients pour cette étude majeure

Biophytis Essai Clinique Sarcopénie Autorisation EMA
PRESS RELEASE

published on 08/28/2025 at 06:59, 5 months 8 days ago

Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie
Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie. Étape majeure dans le développement de thérapies pour la perte musculaire liée à l’âge

Biophytis Essai Clinique Sarcopénie Autorisation EMA
PRESS RELEASE

published on 08/28/2025 at 06:59, 5 months 8 days ago

Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers

Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
BRIEF

published on 08/05/2025 at 23:05, 5 months 30 days ago

Biophytis Secures €1 Million Non-Dilutive Bond Financing

Biophytis Bond Financing Shareholder Impact Non-dilutive OBA101 Program
BRIEF

published on 08/05/2025 at 23:05, 5 months 30 days ago

Biophytis assure 1 million d'euros de financement obligataire

Biophytis Dilution Actionnaires Financement Obligataire Hexagon Capital Fund OBA101 Développement
REGULATED PRESS RELEASE

published on 08/05/2025 at 23:00, 5 months 30 days ago

Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million
Biophytis secures a non-dilutive bond financing line of up to €1 million with Hexagon Capital Fund to support OBA101 program development and strengthen cash position

Biophytis Financing Hexagon Capital Fund OBA101 Program Non-dilutive Bond
REGULATED PRESS RELEASE

published on 08/05/2025 at 23:00, 5 months 30 days ago

Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€
Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€ avec Hexagon Capital Fund pour financer le programme OBA101 et couvrir ses besoins jusqu’au premier trimestre 2026

Biophytis Trésorerie Financement Obligataire Hexagon Capital Fund OBA101
PRESS RELEASE

published on 08/05/2025 at 22:59, 5 months 30 days ago

Biophytis sécurise une ligne de financement obligataire non dilutive jusqu’à 1 M€
Biophytis sécurise une ligne de financement obligataire non dilutive de 1 M€ avec Hexagon Capital Fund pour financer le développement clinique du programme OBA101 jusqu'au T1 2026

Biophytis Obligataire Hexagon Capital Fund Ligne De Financement Dilutive
PRESS RELEASE

published on 08/05/2025 at 22:59, 5 months 30 days ago

Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million
Biophytis secures a non-dilutive bond financing line of up to €1 million from Hexagon Capital Fund. The bonds, with 12% annual interest rate, will mature in 24 months and may be repaid in shares

Biophytis Hexagon Capital Fund Non-dilutive Bond Financing 12% Interest Rate Repayment In Shares
BRIEF

published on 07/30/2025 at 07:05, 6 months 6 days ago

Biophytis Joins Silver Innov' to Boost Silver Economy Initiatives

Biophytis Healthcare Innovation Longevity Sarcopenia Silver Innov'

Accesswire

Published on 02/05/2026 at 01:35, 7 hours 18 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 8 hours 53 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 10 hours 28 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 14 hours 53 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 16 hours 38 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 08:35, 18 minutes ago

EQS-Adhoc: Westwing Group SE: Cancellation of Treasury Shares and Share Buyback
Published on 02/05/2026 at 08:30, 23 minutes ago

Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism
Published on 02/05/2026 at 08:05, 48 minutes ago

OPEC Fund marks 50ᵗʰ anniversary with record US$3.2 billion in development financing
Published on 02/05/2026 at 08:00, 53 minutes ago

Custodian Property Income REIT plc: Disposal of Glasgow Offices at a 24% Premium to Valuation
Published on 02/05/2026 at 08:00, 53 minutes ago

Transaction in Own Shares

Les Echos

Published on 02/04/2026 at 18:04, 14 hours 49 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 14 hours 49 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 15 hours 8 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 15 hours 8 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 15 hours 8 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE